Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

Discover how to live successfully with one kidney through tips on protection, nutrition, and exercise. Learn the four ways ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Advancing Chronic kidney disease care in India hinges on integrating modern diagnostics from early biomarker screening to ...

Kidney disease ranges from mild dysfunction treatable with medication to severe cases requiring dialysis or transplant. Acute ...

A Diabetes, Heart Failure, and Kidney Disease Medication Is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes Feb. 11, 2025 — Over 1,000 genes may serve as possible ...